Cargando…

Examining four blood biomarkers for the detection of acute intracranial abnormalities following mild traumatic brain injury in older adults

Blood-based biomarkers have been increasingly studied for diagnostic and prognostic purposes in patients with mild traumatic brain injury (MTBI). Biomarker levels in blood have been shown to vary throughout age groups. Our aim was to study four blood biomarkers, glial fibrillary acidic protein (GFAP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iverson, Grant L., Minkkinen, Mira, Karr, Justin E., Berghem, Ksenia, Zetterberg, Henrik, Blennow, Kaj, Posti, Jussi P., Luoto, Teemu M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723459/ https://www.ncbi.nlm.nih.gov/pubmed/36484020 http://dx.doi.org/10.3389/fneur.2022.960741

Ejemplares similares

Risk for intracranial hemorrhage in individuals after mild traumatic brain injury who are taking serotonergic antidepressants
por: Isokuortti, Harri, et al.
Publicado: (2022)

Comparing Glial Fibrillary Acidic Protein (GFAP) in Serum and Plasma Following Mild Traumatic Brain Injury in Older Adults
por: Huebschmann, Nathan A., et al.
Publicado: (2020)

Serotonergic Antidepressants and Risk for Traumatic Intracranial Bleeding
por: Isokuortti, Harri, et al.
Publicado: (2021)

A Systematic Review of the Usefulness of Glial Fibrillary Acidic Protein for Predicting Acute Intracranial Lesions following Head Trauma
por: Luoto, Teemu M., et al.
Publicado: (2017)

Tau as a fluid biomarker of concussion and neurodegeneration
por: Hossain, Iftakher, et al.
Publicado: (2022)

Plasma neurofilament light admission levels and development of axonal pathology in mild traumatic brain injury
por: Hossain, Iftakher, et al.
Publicado: (2023)

Prognosis of patients with operated chronic subdural hematoma
por: Posti, Jussi P., et al.
Publicado: (2022)

Admission Levels of Interleukin 10 and Amyloid β 1–40 Improve the Outcome Prediction Performance of the Helsinki Computed Tomography Score in Traumatic Brain Injury
por: Posti, Jussi P., et al.
Publicado: (2020)

Admission Levels of Total Tau and β-Amyloid Isoforms 1–40 and 1–42 in Predicting the Outcome of Mild Traumatic Brain Injury
por: Hossain, Iftakher, et al.
Publicado: (2020)

Craniotomies following acute traumatic brain injury in Finland—a national study between 1997 and 2018
por: Nevalainen, Nea, et al.
Publicado: (2022)

Dynamic prediction of mortality after traumatic brain injury using a machine learning algorithm
por: Raj, Rahul, et al.
Publicado: (2022)

Incidence of acute neurosurgery for traumatic brain injury in children—a nationwide analysis from 1998 to 2018
por: Möttönen, Julius, et al.
Publicado: (2023)

One-Year Prospective Study of Plasma Biomarkers From CNS in Patients With Mild Traumatic Brain Injury
por: Clarke, Gerard Janez Brett, et al.
Publicado: (2021)

Interleukin 10 and Heart Fatty Acid-Binding Protein as Early Outcome Predictors in Patients With Traumatic Brain Injury
por: Lagerstedt, Linnéa, et al.
Publicado: (2020)

Is it time for biomarker-based diagnostic criteria for prodromal Alzheimer's disease?
por: Blennow, Kaj, et al.
Publicado: (2010)

The past and the future of Alzheimer's disease CSF biomarkers—a journey toward validated biochemical tests covering the whole spectrum of molecular events
por: Blennow, Kaj, et al.
Publicado: (2015)

The Past and the Future of Alzheimer’s Disease Fluid Biomarkers(1)
por: Blennow, Kaj, et al.
Publicado: (2018)

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
por: Zetterberg, Henrik, et al.
Publicado: (2021)

Incidence of surgically treated post-traumatic hydrocephalus 6 months following head injury in patients undergoing acute head computed tomography
por: Heinonen, Aaro, et al.
Publicado: (2022)

Improving the Methodology for Identifying Mild Cognitive Impairment in Intellectually High-Functioning Adults Using the NIH Toolbox Cognition Battery
por: Iverson, Grant L., et al.
Publicado: (2021)

High angular resolution diffusion-weighted imaging in mild traumatic brain injury
por: Mohammadian, Mehrbod, et al.
Publicado: (2016)

Post-acute blood biomarkers and disease progression in traumatic brain injury
por: Newcombe, Virginia F J, et al.
Publicado: (2022)

Intracranial arterial four-dimensional flow is associated with metrics of brain health and Alzheimer's disease
por: Berman, Sara E., et al.
Publicado: (2015)

Traumatic Brain Injury and Alzheimer's Disease: The Cerebrovascular Link
por: Ramos-Cejudo, Jaime, et al.
Publicado: (2018)

Lessons from Multicenter Studies on CSF Biomarkers for Alzheimer's Disease
por: Mattsson, Niklas, et al.
Publicado: (2010)

Cerebrospinal Fluid Analysis Should Be Considered in Patients with Cognitive Problems
por: Zetterberg, Henrik, et al.
Publicado: (2010)

Neuroinflammation Screening in Immunotherapy Trials against Alzheimer's Disease
por: Andreasen, Niels, et al.
Publicado: (2010)

Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders
por: Andreasson, Ulf, et al.
Publicado: (2016)

Results of scoping review do not support mild traumatic brain injury being associated with a high incidence of chronic cognitive impairment: Commentary on McInnes et al. 2017
por: Iverson, Grant L., et al.
Publicado: (2019)

Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
por: Cicognola, Claudia, et al.
Publicado: (2021)

Machine learning-based dynamic mortality prediction after traumatic brain injury
por: Raj, Rahul, et al.
Publicado: (2019)

Proteomic blood profiling in mild, severe and critical COVID-19 patients
por: Patel, Hamel, et al.
Publicado: (2021)

Comparison of Brief Cognitive Tests and CSF Biomarkers in Predicting Alzheimer’s Disease in Mild Cognitive Impairment: Six-Year Follow-Up Study
por: Palmqvist, Sebastian, et al.
Publicado: (2012)

Spitting image: can saliva biomarkers reflect Alzheimer's disease?
por: Ashton, Nicholas J., et al.
Publicado: (2021)

Decreased Electroencephalography Global Field Synchronization in Slow-Frequency Bands Characterizes Synaptic Dysfunction in Amnestic Subtypes of Mild Cognitive Impairment
por: Smailovic, Una, et al.
Publicado: (2022)

Association between APOE Genotype and Change in Physical Function in a Population-Based Swedish Cohort of Older Individuals Followed Over Four Years
por: Skoog, Ingmar, et al.
Publicado: (2016)

Use of theragnostic markers to select drugs for phase II/III trials for Alzheimer disease
por: Zetterberg, Henrik, et al.
Publicado: (2010)

Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samples
por: Skillbäck, Tobias, et al.
Publicado: (2013)

Fluid biomarkers in Alzheimer’s disease – current concepts
por: Rosén, Christoffer, et al.
Publicado: (2013)

Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
por: Mattsson, Niklas, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6pgt3d7bqhmrbgvm15u1vvm9mu